Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study

Domenico Pascucci; Adriano Grossi; Alberto Lontano; Eleonora Marziali; Mario Cesare Nurchis; Mario Cesare Nurchis; Vincenzo Maria Grassi; Matteo Raponi; Giuseppe Vetrugno; Giovanni Capelli; Giovanna Elisa Calabro'; Domenico Staiti; Maurizio Sanguinetti; Gianfranco Damiani; Patrizia Laurenti

doi:10.3390/vaccines11010025

Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study

Domenico Pascucci, Adriano Grossi, Alberto Lontano, Eleonora Marziali, Mario Cesare Nurchis, Mario Cesare Nurchis, Vincenzo Maria Grassi, Matteo Raponi, Giuseppe Vetrugno, Giovanni Capelli, Giovanna Elisa Calabro', Domenico Staiti, Maurizio Sanguinetti, Gianfranco Damiani, Patrizia Laurenti

Local Health Authority Asl Roma 1

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	1-15
Number of pages	15
Journal	Vaccines
DOIs	https://doi.org/10.3390/vaccines11010025
Publication status	Published - 2022

Keywords

COVID-19
SARS-CoV-2
booster
health personnel
immunity
mRNA vaccine
vaccination

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/vaccines11010025

Cite this

Pascucci, D., Grossi, A., Lontano, A., Marziali, E., Nurchis, M. C., Nurchis, M. C., Grassi, V. M., Raponi, M., Vetrugno, G., Capelli, G., Calabro', G. E., Staiti, D., Sanguinetti, M., Damiani, G., & Laurenti, P. (2022). Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study. Vaccines, 1-15. https://doi.org/10.3390/vaccines11010025

@article{23682afffd1248d4980cb13e9ff62242,

title = "Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study",

keywords = "COVID-19, SARS-CoV-2, booster, health personnel, immunity, mRNA vaccine, vaccination, COVID-19, SARS-CoV-2, booster, health personnel, immunity, mRNA vaccine, vaccination",

author = "Domenico Pascucci and Adriano Grossi and Alberto Lontano and Eleonora Marziali and Nurchis, {Mario Cesare} and Nurchis, {Mario Cesare} and Grassi, {Vincenzo Maria} and Matteo Raponi and Giuseppe Vetrugno and Giovanni Capelli and Calabro', {Giovanna Elisa} and Domenico Staiti and Maurizio Sanguinetti and Gianfranco Damiani and Patrizia Laurenti",

year = "2022",

doi = "10.3390/vaccines11010025",

language = "English",

pages = "1--15",

journal = "Vaccines",

issn = "2076-393X",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

}

Pascucci, D, Grossi, A, Lontano, A, Marziali, E, Nurchis, MC, Nurchis, MC, Grassi, VM, Raponi, M, Vetrugno, G, Capelli, G, Calabro', GE, Staiti, D , Sanguinetti, M , Damiani, G & Laurenti, P 2022, 'Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study', Vaccines, pp. 1-15. https://doi.org/10.3390/vaccines11010025

TY - JOUR

T1 - Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study

AU - Pascucci, Domenico

AU - Grossi, Adriano

AU - Lontano, Alberto

AU - Marziali, Eleonora

AU - Nurchis, Mario Cesare

AU - Grassi, Vincenzo Maria

AU - Raponi, Matteo

AU - Vetrugno, Giuseppe

AU - Capelli, Giovanni

AU - Calabro', Giovanna Elisa

AU - Staiti, Domenico

AU - Sanguinetti, Maurizio

AU - Damiani, Gianfranco

AU - Laurenti, Patrizia

PY - 2022

Y1 - 2022

KW - COVID-19

KW - SARS-CoV-2

KW - booster

KW - health personnel

KW - immunity

KW - mRNA vaccine

KW - vaccination

KW - COVID-19

KW - SARS-CoV-2

KW - booster

KW - health personnel

KW - immunity

KW - mRNA vaccine

KW - vaccination

UR - http://hdl.handle.net/10807/223764

UR - https://pubmed.ncbi.nlm.nih.gov/36679868/

U2 - 10.3390/vaccines11010025

DO - 10.3390/vaccines11010025

M3 - Article

SN - 2076-393X

SP - 1

EP - 15

JO - Vaccines

JF - Vaccines

ER -

Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study

Keywords

UN SDGs

Access to Document

Other files and links

Cite this